                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> TARGETING LATS1/2 AND THE HIPPO INTRACELLULAR SIGNALING PATHWAY 
      FOR CANCER IMMUNOTHERAPY

<130> UCSDP047WO

<140> PCT/US2017/059310
<141> 2017-10-31

<150> 62/416,414
<151> 2016-11-02

<160> 18    

<170> PatentIn version 3.5

<210> 1
<211> 8
<212> PRT
<213> Gallus gallus

<400> 1
Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210> 2
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      LAGLIDADG family

<400> 2
Leu Ala Gly Leu Ile Asp Ala Asp Gly 
1               5                   


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
agacgttctg ctccgaaatc                                                   20


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
acgtttccat tggcgaatga                                                   20


<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
gagtgtccag cttacaagcg                                                   20


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
gctgggtggt gcaaactacg                                                   20


<210> 7
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
gcctggagaa acctgccaag tatg                                              24


<210> 8
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
gagtgggagt tgctgttgaa gtcg                                              24


<210> 9
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 9
agctgacctg gaggaaaaca                                                   20


<210> 10
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 10
gacaggcttg gcgattttag                                                   20


<210> 11
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 11
gctcagtcag aaggcagacc                                                   20


<210> 12
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 12
gttcttgggg acacagagga                                                   20


<210> 13
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 13
aggagaagag ttgcccacct atgag                                             25


<210> 14
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 14
tcgaagagct tcatcctgtc gc                                                22


<210> 15
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 15
cctgagaaag aagaaacaca gcctc                                             25


<210> 16
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 16
gcaagttggt tgaggaagag aggg                                              24


<210> 17
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 17
gaagagttac actgcctttg ccatc                                             25


<210> 18
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 18
aaacactgtc tgctggtgga gttc                                              24


